ALK and non-small cell lung carcinoma: ALK rearrangements have also been established as a promising molecular target in other malignancies, e.g., non-small cell lung cancer.368 In a 2017 study, five cases harboring an ALK fusion gene were identified via comprehensive genomic profiling of 3170 pancreatic cancer patients.